Section I
1611 – 1620 of 4731
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
(
- Contribution to journal › Article
-
Mark
Tumor tissue protein signatures reflect histological grade of breast cancer
2017) In PLoS ONE(
- Contribution to journal › Article
-
Mark
Re : Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer?
(
- Contribution to journal › Article
-
Mark
The Pharyngoesophageal Segment after Total Laryngectomy
(
- Contribution to journal › Article
-
Mark
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen
(
- Contribution to journal › Article
-
Mark
Outcome of men with relapse after adjuvant carboplatin for clinical stage i seminoma
(
- Contribution to journal › Article
-
Mark
Accelerated or conventional whole brain irradiation of malignant melanoma
(
- Contribution to journal › Letter
-
Mark
Psychosocial Well-Being of Young People Who Participated in a Support Group Following the Loss of a Parent to Cancer
(
- Contribution to journal › Article